The vaccine is licensed to the Pune-based SII and the company has already established production capacity for 100 million doses per annum, which will be doubled over the next two years, it added.
Bengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University s R21 malaria vaccine in Ghana, which approved the shot this month, a Ghanaian vaccine.
The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum Institute of India, on November 30.
Poonawalla cited the obstacles faced during the supply of vaccines at border crossings. Vaccine certificates and clinical trial papers were not being accepted at the start of the pandemic.
Pune news: Believing that messages are from Adar Poonawalla more than Rs 1,01, 01,554 crore was transferred to those accounts by the finance department in different transactions, only to belatedly realise that the SII was duped.